Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.64197 | 60 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.52118 | 59 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.52716 | 59 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.43024 | 58 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.46692 | 58 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.65859 | 60 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.67802 | 60 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.52172 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.46336 | 58 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.48649 | 58 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.52316 | 59 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.45709 | 58 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.56703 | 59 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.52753 | 59 |